Avidity Partners Management LP bought a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 99,000 shares of the medical research company’s stock, valued at approximately $13,764,000. Several other large investors also […]
AdvisorShares Investments LLC bought a new position in Agilent Technologies, Inc. (NYSE:A – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 3,361 shares of the medical research company’s stock, valued at approximately $467,000. Several other hedge funds and other […]
Vinva Investment Management Ltd lifted its position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 33.2% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 10,700 shares of the medical research company’s stock after buying an additional 2,665 shares during the period. Vinva Investment Management […]
Bell Asset Management Ltd bought a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 44,249 shares of the medical research company’s stock, valued at approximately $6,152,000. […]
Agilent Technologies (NYSE:A – Free Report) had its price objective reduced by Barclays from $135.00 to $125.00 in a report released on Friday, Benzinga reports. They currently have an underweight rating on the medical research company’s stock. Other equities research analysts have also recently issued reports about the stock. Stifel Nicolaus cut their price target […]